215 related articles for article (PubMed ID: 4137165)
21. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
22. Chromosome banding, isoenzyme studies and determination of Epstein-Barr virus DNA content on human Burkitt lymphoma/mouse hybrids.
Spira J; Povey S; Wiener F; Klein G; Andersson-Anvret M
Int J Cancer; 1977 Dec; 20(6):849-53. PubMed ID: 201572
[TBL] [Abstract][Full Text] [Related]
23. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay.
Brown TD; Ernberg I; Lamon EW; Klein G
Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574
[No Abstract] [Full Text] [Related]
24. Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt's lymphoma.
Levine PH; O'Conor GT; Bernard CW
Cancer; 1972 Sep; 30(3):610-5. PubMed ID: 4342405
[No Abstract] [Full Text] [Related]
25. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
26. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
[No Abstract] [Full Text] [Related]
28. Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease.
Klein G
Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():783-90. PubMed ID: 169032
[No Abstract] [Full Text] [Related]
29. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
[TBL] [Abstract][Full Text] [Related]
30. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA.
Lanier AP; Bornkamm GW; Henle W; Henle G; Bender TR; Talbot ML; Dohan PH
Int J Cancer; 1981 Sep; 28(3):301-5. PubMed ID: 6274814
[TBL] [Abstract][Full Text] [Related]
31. Letter: E.B. virus and American and African Burkitt's lymphoma.
Levine PH; O'Conor G
Lancet; 1973 Oct; 2(7833):850. PubMed ID: 4126648
[No Abstract] [Full Text] [Related]
32. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Magrath I; Henle W; Owor R; Olweny C
N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
[No Abstract] [Full Text] [Related]
33. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.
Ho M; Miller G; Atchison RW; Breinig MK; Dummer JS; Andiman W; Starzl TE; Eastman R; Griffith BP; Hardesty RL
J Infect Dis; 1985 Nov; 152(5):876-86. PubMed ID: 2995512
[TBL] [Abstract][Full Text] [Related]
34. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
35. Association of Epstein-Barr viral genomes with American Burkitt lymphoma.
Andersson M; Klein G; Zeigler JL; Henle W
Nature; 1976 Mar; 260(5549):357-9. PubMed ID: 176599
[No Abstract] [Full Text] [Related]
36. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
37. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
Magrath IT; Henle W
IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
[No Abstract] [Full Text] [Related]
38. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
[TBL] [Abstract][Full Text] [Related]
39. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
[TBL] [Abstract][Full Text] [Related]
40. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
